Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Express Scripts
Medtronic
Moodys
Mallinckrodt

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

Chartwell Rx Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for CHARTWELL RX, and what generic and branded alternatives to CHARTWELL RX drugs are available?

CHARTWELL RX has fifty-two approved drugs.



Summary for Chartwell Rx
US Patents:0
Tradenames:29
Ingredients:26
NDAs:52

Drugs and US Patents for Chartwell Rx

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx FULVICIN P/G griseofulvin, ultramicrocrystalline TABLET;ORAL 061996-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Chartwell Rx CAM-AP-ES hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 084897-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Chartwell Rx CAM-METRAZINE phendimetrazine tartrate TABLET;ORAL 085320-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Chartwell Rx PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 087915-001 Dec 22, 1983 DISCN No No   Start Trial   Start Trial
Chartwell Rx PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 088576-001 May 23, 1984 DISCN No No   Start Trial   Start Trial
Chartwell Rx TRICHLORMETHIAZIDE trichlormethiazide TABLET;ORAL 085568-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Chartwell Rx FULVICIN P/G 165 griseofulvin, ultramicrocrystalline TABLET;ORAL 061996-003 Apr 6, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Medtronic
AstraZeneca
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.